Human GPSM1/AGS3 ORF/cDNA clone-Adenovirus plasmid (NM_001145638.3)

Cat. No.: pGMAD001694
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human GPSM1/AGS3 adenoviral expression plasmid for GPSM1 adenovirus packaging, GPSM1 adenovirus.

Our GM-Adenovirus vector is optimized with the GMVC-modified Adeasy adenovirus packaging system. Find more about the GMVC-modified adenovirus packaging system.


Purchase
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMAD001694
Gene Name GPSM1
Accession Number NM_001145638.3
Gene ID 26086
Species Human
Product Type Adenovirus plasmid (overexpression)
Insert Length 2028 bp
Gene Alias AGS3
Fluorescent Reporter EGFP
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter EF1
Resistance Kanamycin
ORF Nucleotide Sequence ATGGCGGGCCCGGCCCCGCCCGCGGCCGACGAGCTCCCGGGCCCGGCCGCCAGGCGCCTCTACTCCAGGATGGAGGCGTCCTGCCTAGAGCTGGCGCTGGAGGGCGAGCGTCTGTGCAAGGCGGGCGACTTCAAGACAGGCGTGGCCTTCTTTGAGGCTGCTGTGCAGGTGGGCACCGAGGACCTGAAGACACTGAGTGCCATCTACAGCCAGCTGGGCAACGCCTACTTCTACCTGAAGGAGCACGGCCGGGCGCTGGAATACCACAAGCATGACCTCCTGCTGGCGCGGACCATCGGTGACCGCATGGGGGAGGCCAAGGCCAGTGGAAACCTGGGAAACACACTCAAGGTCCTGGGGCGCTTCGACGAGGCTGCCGTCTGCTGCCAGCGGCATCTGAGCATCGCCCAAGAGCAGGGAGACAAGGTTGGGGAGGCGAGGGCCCTCTACAACATCGGGAACGTGTACCACGCCAAAGGCAAGCAACTGTCCTGGAACGCCGCAAACGCCACGCAGGACCCCGGGCACCTGCCGCCCGATGTCCGAGAGACCCTGTGCAAGGCCTCCGAGTTCTACGAGAGGAACCTGTCCCTGGTGAAGGAGCTGGGCGACCGTGCGGCGCAGGGCAGGGCCTACGGCAACCTGGGCAACACCCACTATTTGTTGGGGAACTTCACAGAGGCCACGACCTTCCACAAGGAGCGCCTGGCCATTGCTAAGGAGTTTGGAGACAAGGCAGCCGAGAGGAGGGCCTACAGCAACCTGGGGAACGCCCACGTCTTCCTGGGGCGCTTTGACGTGGCCGCCGAGTACTACAAGAAGACGCTGCAACTGTCTCGGCAGCTCAGGGACCAGGCAGTGGAGGCGCAGGCCTGCTACAGTCTGGGCAACACCTACACGCTGCTGCAGGACTACGAGCGCGCGGCCGAGTACCACCTGCGGCACCTGCTCATTGCCCAGGAGCTGGCCGACAGAGTGGGCGAGGGCCGGGCGTGCTGGAGCCTGGGAAATGCCTACGTGTCCATGGGGCGCCCAGCGCAGGCCCTGACCTTCGCCAAGAAGCACCTGCAGATCTCCCAGGAGATCGGGGACCGCCATGGGGAGCTCACGGCCCGCATGAACGTGGCGCAGCTGCAGCTGGTGCTCGGCCGCCTGACCAGCCCGGCAGCCTCAGAGAAGCCTGACCTGGCCGGCTATGAGGCCCAGGGGGCCAGACCCAAGAGGACGCAGAGGCTGAGCGCGGAGACCTGGGACCTGCTGAGACTCCCCCTGGAGCGGGAGCAGAATGGAGACAGCCACCATTCAGGGGACTGGCGGGGGCCCAGCAGGGACTCGCTACCCCTCCCCGTGAGGAGCAGGAAGTACCAGGAAGGCCCGGACGCTGAGAGGAGGCCCCGGGAGGGCAGCCACTCCCCGCTGGACAGCGCCGACGTCCGGGTGCACGTGCCACGCACGAGCATCCCGAGGGCCCCGTCTTCGGACGAGGAGTGCTTCTTTGACCTGTTGACCAAGTTCCAGAGCAGCCGCATGGACGACCAGCGTTGTCCCCTGGACGATGGCCAGGCCGGGGCTGCCGAGGCCACGGCCGCCCCCACCCTGGAGGACAGGATCGCCCAGCCCTCGATGACGGCCTCGCCCCAGACCGAGGAATTCTTCGACCTCATCGCCAGCTCCCAGAGCCGCCGGCTGGACGACCAGCGGGCCAGCGTGGGCAGCCTGCCGGGGCTGCGAATCACCCACAGCAATGCAGGGCACCTCCGAGGCCACGGCGAGCCCCAGGAGCCGGGGGACGACTTCTTCAACATGCTCATCAAGTACCAGTCCTCCAGGATCGATGACCAGCGCTGCCCGCCACCTGACGTACTGCCCCGGGGCCCTACCATGCCGGACGAGGACTTCTTCAGCCTCATTCAGAGGGTGCAGGCTAAGCGCATGGACGAGCAGCGGGTGGACCTCGCCGGGGGCCCGGAGCAGGGGGCAGGCGGCCCGCCCGAGCCCCAGCAGCAGTGCCAGCCTGGTGCGAGCTAA
ORF Protein Sequence MAGPAPPAADELPGPAARRLYSRMEASCLELALEGERLCKAGDFKTGVAFFEAAVQVGTEDLKTLSAIYSQLGNAYFYLKEHGRALEYHKHDLLLARTIGDRMGEAKASGNLGNTLKVLGRFDEAAVCCQRHLSIAQEQGDKVGEARALYNIGNVYHAKGKQLSWNAANATQDPGHLPPDVRETLCKASEFYERNLSLVKELGDRAAQGRAYGNLGNTHYLLGNFTEATTFHKERLAIAKEFGDKAAERRAYSNLGNAHVFLGRFDVAAEYYKKTLQLSRQLRDQAVEAQACYSLGNTYTLLQDYERAAEYHLRHLLIAQELADRVGEGRACWSLGNAYVSMGRPAQALTFAKKHLQISQEIGDRHGELTARMNVAQLQLVLGRLTSPAASEKPDLAGYEAQGARPKRTQRLSAETWDLLRLPLEREQNGDSHHSGDWRGPSRDSLPLPVRSRKYQEGPDAERRPREGSHSPLDSADVRVHVPRTSIPRAPSSDEECFFDLLTKFQSSRMDDQRCPLDDGQAGAAEATAAPTLEDRIAQPSMTASPQTEEFFDLIASSQSRRLDDQRASVGSLPGLRITHSNAGHLRGHGEPQEPGDDFFNMLIKYQSSRIDDQRCPPPDVLPRGPTMPDEDFFSLIQRVQAKRMDEQRVDLAGGPEQGAGGPPEPQQQCQPGAS

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    ORF Viral Vector vGMAD001694 Human GPSM1 Adenovirus particle




    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.